Which is better, Obinutuzumab or Dalbituzumab?

Obinutuzumab is the trade name of dupilumab injection (Dupilumab). Obinutuzumab and dupilumab are two drugs that treat different indications. Their mechanisms of action are different, and the therapeutic effects are also different, so comparison may not be possible. Otuzumab is a humanized anti CD20 monoclonal antibody that can be used as first-line treatment in chronic lymphocytic leukemia in combination with chemotherapy or in combination with venetoclax, as first-line treatment in follicular lymphoma in combination with chemotherapy, and as a treatment in combination with bendamustine for relapsed or refractory follicular lymphoma. Duplimumab is a fully human monoclonal antibody of the immunoglobulin G4 subclass, indicated for the treatment of moderate to severe atopic dermatitis, asthma, and nasal polyps associated with chronic sinusitis in adolescents and adults.